Muteins of mammalian cytokine interleukin-13
US5696234A · kind A · utility
42Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 1994 |
| Grant date | Dec 9, 1997 |
| Priority date | — |
| Expiry date | Aug 1, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for screening for partial agonists and for antagonists of mammalian cytokines. Particular positions of natural cytokines are identified as critical in providing these receptor mediated properties. Specific embodiments demonstrate properties of variations at these positions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.